MétaCan
Menu
← Retour à la cohorte
Enregistrement W2329688698 · doi:10.1097/01.cot.0000415257.78521.3c

Greater Node Sampling Urged in Lung Surgery

2012· article· en· W2329688698 sur OpenAlexaboutno aff
Cynthia Washam

Notice bibliographique

RevueOncology Times · 2012
Typearticle
Langueen
DomaineMedicine
ThématiqueLung Cancer Diagnosis and Treatment
Établissements canadiensnon disponible
Organismes subventionnairesnon disponible
Mots-clésSampling (signal processing)MedicineGeneral surgerySurgeryComputer scienceTelecommunications

Résumé

récupéré en direct d'OpenAlex

FigureThoracic surgeons at major cancer centers are urging their colleagues at community hospitals to follow their lead in lymph-node sampling. "Many colleagues who do complete lobectomies only once in a while don't have the interest to do lymph-node sampling," said Steven Keller, MD, Clinical Professor of Cardiovascular and Thoracic Surgery at Albert Einstein College of Medicine and Co-Director of the Cardiothoracic Surgery Residency Program at Montefiore Medical Center. "Those of us who do only thoracic surgery will generally remove the nodes." Keller and other advocates for rigorous sampling warn that surgeons who remove too few nodes hamper staging. That, in turn, could delay chemotherapy that might benefit stage II or III patients. "The more lymph nodes you remove," Keller said, "the more accurately you stage the patient." Frank Detterbeck, MD, Professor of Surgery and Chief of Thoracic Surgery at Yale Cancer Center, concurs. Stage II and III, ideally, should get chemotherapy. You do have a higher chance of curing them." Eric Vallieres, MD, Surgical Director for Lung Cancer at the Swedish Cancer Institute in Seattle, says that inadequate node sampling forces oncologists into guesswork: "It's very hard for an oncologist to make a recommendation for or against chemotherapy when he doesn't have information." Another argument for extensive node sampling is that it's normally required for enrolling patients in clinical trials: "Many patients are not eligible for trials because there are not sufficient [lymph-node] levels sampled or dissected," Keller noted.FRANK DETTERBECK, MD, said that some surgeons wrongly assume that all nodal cancers will show up in a PET scan. "PET scanning is not a very good way to assess the mediastinal. The false-negative rate is pretty high."STEVEN KELLER, MD, warned that surgeons who remove too few nodes hamper staging, which, in turn, could delay chemotherapy that might benefit stage II or III patients. "The more lymph nodes you remove, the more accurately you stage the patient."Still another reason for lymphadenectomy, advocates say, is a potential therapeutic benefit for higher-stage patients. "I think the data at least for early-stage lung cancer is no," said Detterbeck. "Stage II and III, we don't know." Recommended Stations for Sampling Although some studies recommend a certain number of nodes to be sampled, the surgeons interviewed for this article said they base their recommendations on stations sampled. The recommended mediastinal stations for sampling in right-sided cancers are 2R, 4R, 7, 8, and 9. For left-sided cancers, the stations are 4L, 5, 6, 7, 8 and 9. Systematic sampling involves taking at least one node from each recommended station. A study published last year by the American College of Surgeons Oncology Group, based on data from 1999 to 2004 (J Thorac Cardiovasc Surg 2011;141:662–670), revealed occult N2 disease in the nodes of approximately four percent of 1,111 lobectomy patients. Ninety percent of them had at least 10 nodes taken from three stations. "The important thing is that one or more nodes are sampled systematically from standard lymph-node stations," said the lead author, Gail Darling, MD, Director of Clinical Research for Thoracic Surgery at Toronto General Hospital and Professor of Thoracic Surgery at the University of Toronto. "Generally, we would recommend at least three mediastinal lymph node stations including the subcarinal node, as well as the hilar lymph node and intralobar nodes—so this translates to a minimum of six nodes, but 10 or more would be better." The study showed no improvements in survival from going beyond systematic sampling to complete mediastinal dissection—removing all nodes from the recommended stations. "There's pretty good evidence that in terms of staging a patient accurately, whether you do systematic sampling or complete node dissection, you pretty much end up with the same stage," Keller said. Data from the NCI's Surveillance, Epidemiology and End Results (SEERS) database also suggests that systematic sampling is as beneficial as mediastinal dissection. Between 1990 and 2000, some 16,800 patients with non-small-cell lung cancer showed a modest improvement in survival when five to eight lymph nodes were examined (Chest 2005;128:1545–1550). Evaluating more than 16 nodes had no additional benefit. Yet, Keller and the other surgeons interviewed routinely perform complete mediastinal dissections in their lobectomy cancer patients, saying that they feel there are too few studies to disprove a benefit in later-stage patients and that morbidity from dissection is low. "I feel as if complete mediastinal dissection is better sampling," he said.GAIL DARLING, MD: "Generally, we would recommend at least three mediastinal lymph node stations including the subcarinal node, as well as the hilar lymph node and intralobar nodes—so this translates to a minimum of six nodes, but 10 or more would be better."Incentives Lacking With no enforced standards on node removal, many surgeons have little incentive to sample beyond nodes that look suspicious. "It adds to the time and complexity of the surgery," said Heather Wakelee, MD, Assistant Professor of Medicine, Oncology, at Stanford University and a thoracic oncologist at Stanford Clinical Cancer Center. "It's easier not to add that component. Surgeons are not thinking like cancer doctors." Guidelines from the National Cancer Institute and National Comprehensive Cancer Network lack teeth, those interviewed for this article said. Unlike guidelines on colorectal nodes, those for lung nodes typically are not used in evaluating hospital quality. Nor do insurers cover node removal during lobectomy. Surgeons estimate that systematic sampling adds 15 to 20 minutes to the surgery. There is also a belief among thoracic surgeons that most of the surgeons who eschew node sampling are general or heart surgeons practicing in community hospitals. "A lot of thoracic surgery is done by general and cardiac surgeons," Detterbeck said. "They're doing [lobectomies] sporadically. I don't think they do that good a job." A study on patterns of surgical care published in 2005 by the American College of Surgeons Commission on Cancer (Ann Thorac Surg 2005;80:2051–2056) showed that node biopsies indeed vary by setting. While nearly 52% of patients in teaching hospitals had lymph-node biopsies, the practice dropped to 45% in comprehensive community cancer centers and to 40% in community cancer centers. Some surgeons wrongly assume that all nodal cancers will show up in a PET scan, said Detterbeck. "PET scanning is not a very good way to assess the mediastinal. The false-negative rate is pretty high." Needed: Quality Metrics He and others have called for enforceable guidelines for node sampling, noting, though, that a major hurdle is deciding just what is optimal sampling. "We need quality metrics. It's difficult to assign a number of nodes. We need to come up with an appropriate quality measure," Detterbeck said. Until guidelines are enforced, he and other advocates recommend pressuring reluctant surgeons to sample systematically. "Pulmonologists and oncologists should expect at least one lymph node to be assessed from three mediastinal node stations," Darling said, "and if they are not getting that information, they should go back to their surgeon and ask, ‘What about the mediastinal nodes?’"HEATHER WAKELEE, MD, notes that with no enforced standards on node removal, many surgeons have little incentive to sample beyond nodes that look suspicious. "It adds to the time and complexity of the surgery. It's easier not to add that component. Surgeons are not thinking like cancer doctors," she said.Keller suggests a business approach: "Most surgeons are like small-business owners – They respond to their customers. You need to get on the phone and say, ‘Next time I need lymph nodes in the report or I'll send my patients elsewhere.’"

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,010
score de la tête « metaresearch » (Gemma)0,025
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Sans objet · Signal consensuel: Sans objet
GenreSignal candidat: Commentaire · Signal consensuel: Commentaire
Score de désaccord entre enseignants0,015
Score d'incertitude au seuil0,055

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0100,025
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,001
Bibliométrie0,0010,000
Études des sciences et des technologies0,0020,003
Communication savante0,0030,003
Science ouverte0,0010,002
Intégrité de la recherche0,0030,008
Charge utile insuffisante (le modèle a refusé de juger)0,0150,002

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,045
Tête enseignante GPT0,348
Écart entre enseignants0,304 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeSans objet
Domainenon disponible
GenreCommentaire

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2012
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueOncology Times→Même sujetLung Cancer Diagnosis and Treatment→Travaux en français237 207→